Skip to main content
. 2018 May 30;13:3223–3233. doi: 10.2147/IJN.S158884

Table 2.

SLN zeta potentials

SLN reference Zeta potential (mV)
12 38.3
13 35.3
14 35.7
15 29.5
16 41.9

Notes: Composition of the engineered nanoparticles – reference 12: 400 mg stearic acid, 100 mg cholesteryl oleate, 600 mg octadecylamine, 100 mg poloxamer 188; reference 13: 300 mg stearic acid, 200 mg cholesteryl oleate, 600 mg octadecylamine, 100 mg poloxamer 188; reference 14: 200 mg stearic acid, 300 mg cholesteryl oleate, 600 mg octadecylamine, 100 mg poloxamer 188; reference 15: 100 mg stearic acid, 400 mg cholesteryl oleate, 600 mg octadecylamine, 100 mg poloxamer 188; reference 16: 0 mg stearic acid, 500 mg cholesteryl oleate, 600 mg octadecylamine, 100 mg poloxamer 188.

Abbreviation: SLN, solid lipid nanoparticle.